Early discontinuation of biological therapy among inflammatory bowel disease patients in Bahrain: Real world experience

BACKGROUND: Despite the effectiveness of several biological agents in the treatment of inflammatory bowel disease (IBD), some patients respond better than others. Such discrepancies are often evident early in the treatment course. The aim of this study is to identify the risks and assess the rate of...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulla, Maheeba, AlQamish, Jehad, Mohammed, Nafeesa, Al Saeed, Mahmood, Aali, Hasan Jawad Al, Al Khaja, Aysha, Hasan, Zahra Abdulla Isa Yusuf, Haider, Fatema Yusuf, Ebrahim, Sayed Dhiyaa Noor, Mahfoodh, Zahra Sayed Alawi, Hubail, Mahmood Ali Hasan, Alhajri, Isa, Al-Matrook, Fatema, Tork, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212118/
https://www.ncbi.nlm.nih.gov/pubmed/35083972
http://dx.doi.org/10.4103/sjg.sjg_336_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212118/
https://www.ncbi.nlm.nih.gov/pubmed/35083972
http://dx.doi.org/10.4103/sjg.sjg_336_21

Ejemplares similares